Company Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 12:16:51 2024-07-05 pm EDT 5-day change 1st Jan Change
0.14 USD +17.06% Intraday chart for Pressure BioSciences, Inc. +9.98% -57.58%

Business Summary

Pressure BioSciences, Inc. is engaged in the development and sale of enabling, high pressure technology-based instruments, consumables, and services for the life sciences and other industries worldwide. Its products/services are based on three high-pressure platforms: Ultra Shear Technology (UST), BaroFold Technology (BaroFold), and Pressure Cycling Technology (PCT). The UST platform allows for the creation of stable nanoemulsions of otherwise immiscible oil-based active components in water. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. PCT utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The BaroFold platform provides valuable contract services and GMP manufacturing equipment to the biopharmaceutical industry.

Sales per Business

USD in Million2022Weight2023Weight Delta
Hardware
58.6 %
1 44.0 % 1 58.6 % +52.43%
Consumables
10.6 %
0 14.9 % 0 10.6 % -18.68%
Agrochem Products
9.2 %
0 9.5 % 0 9.2 % +9.70%
Technical Support/Extended Service Contracts
7.9 %
0 10.1 % 0 7.9 % -10.34%
Sample Preparation Accessories
6.7 %
0 7.6 % 0 6.7 % +0.76%
Contract Research Services
4.3 %
0 11.3 % 0 4.3 % -56.12%
Shipping and Handling
2.3 %
0 2.4 % 0 2.3 % +7.14%
Other
0.4 %
0 0.1 % 0 0.4 % +300.00%

Sales per region

USD in Million2022Weight2023Weight Delta
North America
69.1 %
1 68.9 % 1 69.1 % +14.69%
Asia
24.1 %
0 22.8 % 0 24.1 % +20.81%
Europe
6.9 %
0 8.3 % 0 6.9 % -5.56%

Managers

Managers TitleAgeSince
Chief Executive Officer 73 78-07-31
Chief Tech/Sci/R&D Officer 70 06-04-23
Chief Tech/Sci/R&D Officer 59 06-04-02
Sales & Marketing 62 20-03-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 73 78-07-31
Director/Board Member 71 13-02-07
Chairman 68 11-06-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 75 0 0 99.34 %
Stock B 0 401 0 0
Stock C 1 34,710,509 34,489,180 ( 99.36 %) 0
Stock D 0 8,645 0 0

Shareholders

NameEquities%Valuation
70,558 0.2741 % 16 228 $
56,207 0.2184 % 12 928 $
33,873 0.1316 % 7 791 $
30,287 0.1177 % 6 966 $
15,479 0.0601 % 3 560 $
14,782 0.0574 % 3 400 $
Edmund Ting
0.003166 %
815 0.003166 % 187 $
NameEquities%Valuation
200 0.1376 % 46 $
20 0.0138 % 5 $
NameEquities%Valuation
65 0.8646 % 15 $
32 0.4256 % 7 $
26 0.3458 % 6 $
21 0.2793 % 5 $
20 0.2660 % 5 $
4 0.0532 % 1 $
NameEquities%Valuation
20 0.1752 % 5 $

Company contact information

Pressure BioSciences, Inc.

480 Neponset Street

02021, Canton

+

http://www.pressurebiosciences.com
address Pressure BioSciences, Inc.(PBIO)
  1. Stock Market
  2. Equities
  3. PBIO Stock
  4. Company Pressure BioSciences, Inc.